Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Devillier

Showing results (11-20 of 147) with videos related to

Pageof 15
Sort By:
Revue Medicale De Bruxelles|December 31, 1997
[The anti-leukotrienes: their use in asthma]P Devillier, H Millart, C Advenier
Pharmacological Research|June 24, 1999
Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part II: clinical studies with leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthmaP Devillier, N Baccard, C Advenier
Revue Des Maladies Respiratoires|January 1, 1988
[The nonadrenergic, noncholinergic neuropeptide system and asthma]P Devillier, R Matran, J Marsac
Pharmacological Research|June 24, 1999
Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part I: synthesis, receptors and role of leukotrienes in asthmaP Devillier, N Baccard, C Advenier
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 30, 2016
Comparison of scores associating symptoms and rescue medication use for evaluating the efficacy of allergy immunotherapy in seasonal allergic rhinoconjunctivitis: results from five trialsJ-M Grouin, E Vicaut, P Devillier
Allergy|October 15, 2015
House dust mite sublingual immunotherapy is safe in patients with mild-to-moderate, persistent asthma: a clinical trialP Devillier, R Fadel, O de Beaumont
Revue Des Maladies Respiratoires|December 25, 2009
[Why and how to measure and optimize lung deposition of inhaled drugs]P Devillier, E Naline, J-C Dubus
Allergy|November 3, 2010
The allergen challenge chamber: a valuable tool for optimizing the clinical development of pollen immunotherapyP Devillier, M Le Gall, F Horak
British Journal of Pharmacology|February 1, 1988
Influence of epithelium on the responsiveness of guinea-pig isolated trachea to adenosineC Advenier, P Devillier, R Matran, et al.
Allergy|October 15, 2015
Prevalence and reversibility of lung hyperinflation in adult asthmatics with poorly controlled disease or significant dyspneaT Perez, P Chanez, D Dusser, et al.
Pageof 15

Showing results (11-20 of 147) with videos related to

Sort By:
Pageof 15
Revue Medicale De Bruxelles|December 31, 1997
[The anti-leukotrienes: their use in asthma]P Devillier, H Millart, C Advenier
Pharmacological Research|June 24, 1999
Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part II: clinical studies with leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthmaP Devillier, N Baccard, C Advenier
Revue Des Maladies Respiratoires|January 1, 1988
[The nonadrenergic, noncholinergic neuropeptide system and asthma]P Devillier, R Matran, J Marsac
Pharmacological Research|June 24, 1999
Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part I: synthesis, receptors and role of leukotrienes in asthmaP Devillier, N Baccard, C Advenier
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 30, 2016
Comparison of scores associating symptoms and rescue medication use for evaluating the efficacy of allergy immunotherapy in seasonal allergic rhinoconjunctivitis: results from five trialsJ-M Grouin, E Vicaut, P Devillier
Allergy|October 15, 2015
House dust mite sublingual immunotherapy is safe in patients with mild-to-moderate, persistent asthma: a clinical trialP Devillier, R Fadel, O de Beaumont
Revue Des Maladies Respiratoires|December 25, 2009
[Why and how to measure and optimize lung deposition of inhaled drugs]P Devillier, E Naline, J-C Dubus
Allergy|November 3, 2010
The allergen challenge chamber: a valuable tool for optimizing the clinical development of pollen immunotherapyP Devillier, M Le Gall, F Horak
British Journal of Pharmacology|February 1, 1988
Influence of epithelium on the responsiveness of guinea-pig isolated trachea to adenosineC Advenier, P Devillier, R Matran, et al.
Allergy|October 15, 2015
Prevalence and reversibility of lung hyperinflation in adult asthmatics with poorly controlled disease or significant dyspneaT Perez, P Chanez, D Dusser, et al.
Pageof 15